Biotechnology Stocks
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 7335 |  OABI OmniAb, Inc. - Common Stock | 4.25 USD | -1.85% | +3.16% | +106.31% | +148.54% | 24.65 M USD | ||
| 7337 |  JSPRW Jasper Therapeutics, Inc. - Warrant | 0.0120 USD | -0.83% | +22.45% | +30.43% | -82.88% | 22.63 M USD | ||
| 7362 |  ICUCW SeaStar Medical Holding Corporation - Warrant | 0.0196 USD | 0.00% | -0.51% | +3.16% | -44.16% | 14.98 M USD | ||
| 7363 |  BIVIW BioVie Inc. - Warrant | 0.2600 USD | -7.14% | +30.00% | -36.59% | -33.33% | 14.03 M USD | ||
| 7366 |  NRSNW NeuroSense Therapeutics Ltd. - Warrant | 0.0446 USD | 0.00% | -40.53% | -36.10% | -91.89% | 12.05 M USD | ||
| 7369 |  ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0131 USD | -17.09% | -37.62% | -27.62% | -79.85% | 11.08 M USD | ||
| 7390 |  CDIOW Cardio Diagnostics Holdings Inc. - Warrant | 0.0175 USD | 0.00% | +47.06% | +2.94% | +6.06% | 5.71 M USD | ||
| 7391 |  DRMAW Dermata Therapeutics, Inc. - Warrant | 0.0006 USD | 0.00% | -25.00% | -92.50% | -97.18% | 5.75 M USD | ||
| 7392 |  MLECW Moolec Science SA - Warrant | 0.0160 USD | 0.00% | +1.91% | -18.78% | +39.13% | 5.08 M USD | ||
| 7401 |  REVBW Revelation Biosciences, Inc. - Warrant | 0.0065 USD | -2.99% | -30.11% | 0.00% | -40.91% | 4.34 M USD | ||
| 7403 |  SXTPW 60 Degrees Pharmaceuticals, Inc. - Warrant | 0.0355 USD | -5.08% | 0.00% | +26.79% | -70.19% | 3.97 M USD | ||
| 7412 |  CDTTW CDT Equity Inc. - Warrant | 0.0099 USD | +3.13% | -13.91% | -18.85% | -41.76% | 2.17 M USD | ||
| 7415 |  SLXNW Silexion Therapeutics Corp - Warrant | 0.0107 USD | 0.00% | -17.05% | -66.77% | -64.33% | 2.17 M USD | ||
| 7429 |  KTTA Pasithea Therapeutics Corp. - Common Stock | 0.53 USD | -1.85% | +6.00% | +12.77% | -27.40% | 227.22 K USD |
Noticias Biotechnology Stocks
Deutsche Bank rebaja argenx a Mantener por valoración
¿Por qué cae hoy la acción de Monte Rosa Therapeutics?
Las acciones de Biomea Fusion se disparan tras completar el ensayo sobre diabetes
Las acciones de Monte Rosa caen al inicio de un estudio de fase 2 contra el cáncer de próstata
Las acciones de Crinetics Pharmaceuticals alcanzan máximos históricos en 84,8 dólares
H.C. Wainwright reitera su calificación de Biomea Fusion tras inscripción en ensayo
La FDA amplía la revisión de deramiocel de Capricor hasta el 22 de noviembre
Gainers Biotechnology Stocks
 SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
 RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
 ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
 NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
 LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
 BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
 ELOX Eloxx Pharmaceuticals, Inc. | 20.97 | +16.24% |
Losers Biotechnology Stocks
 OABIW OmniAb, Inc. - Warrant | 0.1700 | -40.27% |
 CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
 RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0131 | -17.09% |
 ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
 APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
 BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
 YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |